| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(00)80192-0 |
| P698 | PubMed publication ID | 10673070 |
| P2093 | author name string | K Endo | |
| T Terada | |||
| P2860 | cites work | Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas | Q71627798 |
| Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas | Q71650377 | ||
| Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins | Q71657938 | ||
| Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects | Q71672814 | ||
| CD44 expression in normal and inflamed skin | Q72913299 | ||
| Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study | Q73137127 | ||
| CD44 splice variants as prognostic markers in colorectal cancer | Q74267432 | ||
| Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study | Q74428416 | ||
| Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas | Q74447044 | ||
| Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma | Q77308619 | ||
| A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells | Q28578219 | ||
| Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis | Q34407461 | ||
| CD44 and the adhesion of neoplastic cells | Q37227543 | ||
| Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons | Q37352620 | ||
| Splicing choice from ten variant exons establishes CD44 variability | Q40405801 | ||
| Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma | Q41936556 | ||
| De-novo expression of CD44 and survival in gastric cancer | Q42483834 | ||
| CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation | Q42519376 | ||
| Prevention of tumor metastasis formation by anti-variant CD44. | Q42941570 | ||
| Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas | Q48501706 | ||
| CD44 is an independent prognostic factor in early-stage cervical cancer. | Q53360218 | ||
| Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. | Q53435467 | ||
| CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. | Q53472844 | ||
| Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in france | Q58408891 | ||
| CD44 variant exon epitopes in primary breast cancer and length of survival | Q61970404 | ||
| CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. | Q64933149 | ||
| Significance of CD44 gene products for cancer diagnosis and disease evaluation | Q67522125 | ||
| Expression of ABH blood group antigens, receptors of ulex europaeus agglutinin I, and factor VIII-Related antigen on sinusoidal endothelial cells in adenomatous hyperplasia in human cirrhotic livers | Q67916356 | ||
| CD44 is expressed in hepatocellular carcinomas showing vascular invasion | Q71218248 | ||
| P433 | issue | 1 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 78-84 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival | |
| P478 | volume | 32 |
| Q53664864 | A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. |
| Q36089938 | A morpho-molecular prognostic model for hepatocellular carcinoma |
| Q35064510 | Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma |
| Q53334223 | An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. |
| Q35782494 | CD44 expression in patients with combined hepatocellular cholangiocarcinoma |
| Q58775431 | CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands |
| Q33757826 | CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features |
| Q90397544 | CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field |
| Q35280672 | Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs |
| Q26768643 | Cellular Barriers after Extravasation: Leukocyte Interactions with Polarized Epithelia in the Inflamed Tissue |
| Q38309029 | Cervical cancer stem cells: opportunities and challenges |
| Q39239161 | Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. |
| Q34357073 | Clinical implications of cancer stem cell biology in hepatocellular carcinoma |
| Q39419867 | Clinical implications of microRNAs in liver cancer stem cells. |
| Q37899575 | Contribution of biomarkers and imaging in the management of hepatocellular carcinoma |
| Q39183455 | Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model. |
| Q36119526 | Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer |
| Q40800883 | Differential expression of CD44 isoforms during liver regeneration in rats. |
| Q39774120 | Effects of angiopoietin-1 on attachment and metastasis of human gastric cancer cell line BGC-823 |
| Q37190234 | Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells. |
| Q46867815 | Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma |
| Q35477709 | Ex vivo hepatic venography for hepatocellular carcinoma in livers explanted for liver transplantation |
| Q38449312 | Expression of beta-catenin, COX-2 and iNOS in colorectal cancer: relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia. |
| Q35119166 | Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma. |
| Q35568362 | Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression |
| Q49952146 | H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma |
| Q38930438 | Hyaluronic acid in digestive cancers |
| Q35837359 | Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer |
| Q54217314 | IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. |
| Q38697891 | Identification of rhodamine 123-positive stem cell subpopulations in canine hepatocellular carcinoma cells |
| Q46076338 | Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients |
| Q36499912 | Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation |
| Q35550186 | Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells. |
| Q35781432 | Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition |
| Q61714951 | Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling |
| Q91022860 | Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms |
| Q26853543 | Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival |
| Q34571624 | Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential |
| Q92332162 | Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway |
| Q59137664 | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
| Q40190754 | Novel hepatic progenitor cell surface markers in the adult rat liver |
| Q38872768 | Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis |
| Q36067470 | Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q41233768 | Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance |
| Q43439182 | Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma |
| Q46245997 | Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection |
| Q64966522 | Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics. |
| Q90411487 | The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target |
| Q26747319 | The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer |
| Q39588313 | The expression levels of CD44v6 are correlated with the invasiveness of hepatocellular carcinoma in vitro, but do not appear to be clinically significant |
| Q37970351 | The molecular pathogenesis and clinical implications of hepatocellular carcinoma |
| Q101476066 | The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q28199313 | The role of the CD44/ezrin complex in cancer metastasis |
| Q49609694 | Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma via suppression of CD44s and the ERK1/2 pathway. |
| Q39635207 | miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. |
Search more.